3 Dividend Stocks That Are No-Brainer Buys Right Now
There are well over 5,000 stocks on the market that pay dividends. It would take you years to analyze each one of them in detail. Fortunately, you don't have to exert such an effort.
Three Fool.com contributors have identified dividend stocks that they think are no-brainers to buy right now. Here's why they picked (NYSE: ABBV), Eli Lilly (NYSE: LLY), and Gilead Sciences (NASDAQ: GILD).
Keith Speights (AbbVie): AbbVie's top-selling drug Humira has lost its U.S. patent exclusivity. Longtime CEO Rick Gonzalez is passing the baton to Rob Michael, who currently serves as the company's president and COO. In more ways than one, it's a new stage for the big drugmaker. But I think it will be a good one.
Source Fool.com
AbbVie Inc. Aktie
171,86 €
1,21 %
Klare Kaufempfehlung: AbbVie Inc. erhält nur Buy-Einschätzungen.
Das Kursziel von 180 € für AbbVie Inc. impliziert eine leichte Steigerung gegenüber dem aktuellen Kurs von 171.86 €.
